PIK3CA and breast carcinoma: Studies presented herein support a wider impact of mTORC1 signaling on Mcl-1 expression, highlighting the mTORC1-to-Mcl-1 axis in PIK3CA-wild type ER+ breast cancer cells (e.g. HCC1428).